Multiple sclerosis affects roughly 900,000 people in the United States, according to the National Multiple Sclerosis Society. For many of these individuals, standard treatments help manage symptoms, but they may not work equally well for everyone. Some people experience side effects that make their current medications difficult to tolerate. Others find that their MS progresses despite treatment, or they develop new symptoms that existing therapies don't address effectively.
Learn About Paying Your FGUA Bill Online →
Clinical trials represent one avenue where people living with MS can explore newer or different treatment approaches. These research studies test whether experimental medications, therapies, or treatment combinations work better than current options. Unlike waiting for a medication to become available through standard channels, trial participants may gain access to treatments years before they're publicly obtainable—though this comes with the understanding that outcomes are not guaranteed and side effects may be unknown.
Clinical trials also benefit the broader MS community. Data collected from trial participants directly informs which treatments eventually reach patients nationwide. Without people willing to participate in research, the medications and therapies doctors prescribe today would not exist. Some participants report that being part of a trial gives them a sense of purpose, knowing their participation may help future patients.
The decision to join a trial is deeply personal. Understanding what trials involve, what questions to ask, and where to find them is the foundation for making an informed choice about whether participation makes sense for your situation.
Practical takeaway: Before exploring specific trials, reflect on why you're interested in participation. Are you seeking additional treatment options, hoping to contribute to research, or managing side effects from current medications? This clarity will help you evaluate which trials might align with your goals.
MS clinical trials follow a specific progression called phases, each serving a different research purpose. Phase 1 trials typically involve a small group of participants (20-100 people) and focus on basic safety and dosage. Phase 2 trials expand to a larger group and begin measuring whether a treatment shows promise for the intended condition. Phase 3 trials involve hundreds or even thousands of participants and compare the experimental treatment against a standard therapy or placebo to determine real-world effectiveness. Phase 4 trials, conducted after a treatment is already approved and available, monitor long-term effects and safety in broader populations.
Free Guide to Pay by Plate Illinois Billing →
Most MS trials are randomized, meaning participants are assigned to either the experimental treatment group or a control group by chance, not by choice. Some trials are "blinded," where neither the participant nor the researcher knows who received the actual treatment versus the placebo. This design prevents bias from influencing results. Other trials are "open-label," where everyone knows what treatment they're receiving.
Every legitimate clinical trial must obtain approval from an Institutional Review Board (IRB) before beginning. The IRB reviews the study design, safety measures, and participant protections. Throughout the trial, an independent Data Safety Monitoring Board periodically reviews results to watch for unexpected side effects or safety concerns that might require stopping or modifying the study.
Trials also have clearly defined protocols—detailed instructions about what happens during the study. You should understand the protocol before participating. It outlines how often you'll visit the clinic, what tests or procedures you'll undergo, how long the trial lasts, and what happens if you experience side effects.
Practical takeaway: Request the full study protocol and discuss it with your neurologist before committing. Pay particular attention to the trial phase, whether it's randomized or open-label, how long it runs, and what the monitoring schedule looks like. These details directly affect your time commitment and the predictability of your experience.
The primary resource for locating clinical trials is ClinicalTrials.gov, a database maintained by the National Institutes of Health. This free, searchable website contains information about thousands of studies worldwide. To search for MS trials, visit the site, select "Condition or Disease" as your search category, type "multiple sclerosis," and filter by location (your state or country), trial phase, and recruitment status. You can refine results to show only trials that are actively enrolling participants.
Free Guide to Mold Removal Methods for Walls →
Beyond the government database, several MS-focused organizations maintain their own trial registries. The National Multiple Sclerosis Society website includes information about trials and links to research opportunities. Some pharmaceutical companies post trial information directly on their websites. University medical centers and teaching hospitals often have neurology departments actively recruiting for MS studies.
When you find a trial that interests you, the listing typically includes the trial's official name, the research organization conducting it, a summary of what the study investigates, the phase, recruitment status, study sites (physical locations where you'd participate), and contact information. Some listings include inclusion and exclusion criteria—characteristics that determine whether someone might participate. Common criteria include your MS type (relapsing-remitting, progressive, etc.), disease duration, current medication use, and other health conditions you may have.
Before contacting a trial, prepare basic information about yourself: your MS diagnosis date, your current treatments, any other medications you take, significant health conditions, and your location. Researchers will ask these questions during initial screening conversations. Having this information organized helps you communicate clearly and shows you've thought seriously about participation.
You may also encounter trials through your neurologist. Many specialists know about active research in their area and may mention opportunities during routine appointments if they think you might be a suitable participant.
Practical takeaway: Start with ClinicalTrials.gov and spend time reading through several trial summaries, even if you don't immediately plan to participate. Familiarizing yourself with trial language, what researchers are currently studying, and the range of options available builds your understanding of the landscape. Bookmark trials that interest you and return to them if your circumstances change.
Once you contact a trial coordinator, the process begins with an initial conversation—usually by phone. The coordinator will ask about your medical history, current symptoms, and treatments. They'll explain the study in basic terms and answer preliminary questions. This is a good moment to ask whether you appear to fit the trial's requirements based on what you've shared. If you seem like a potential match, the next step is usually a screening visit.
How to Delete Your Fitbit Account Guide →
During the screening visit, you'll undergo tests and examinations to confirm you truly meet the trial's criteria. For MS trials, this might include an MRI to assess your current disease activity, blood work, neurological exams, walking tests (like the Timed 25-Foot Walk), or assessments of your cognitive function or fatigue levels. These baseline measurements establish your starting point. If the trial involves a medication, you may have additional tests to ensure your liver, kidneys, and other organs can tolerate the drug.
If screening confirms you're suitable, you'll typically sign an informed consent document. This lengthy document explains what the trial involves, potential risks, your rights as a participant, and what happens if you're injured during the study. You have the right to ask questions and take time to review this document before signing. Many people find it helpful to have their neurologist review the consent form and discuss any concerns.
During the active phase of the trial, your schedule depends entirely on the study design. Some trials require monthly clinic visits; others may require weekly visits or longer intervals. You'll receive the study treatment (medication, infusion, device, or other intervention) according to the protocol. You'll be asked to report any side effects, complete symptom logs, or keep health diaries. The research team will run periodic tests to measure whether the treatment is working and to monitor your safety.
You can withdraw from a trial at any time, for any reason, without penalty. If you experience a serious side effect, the research team has an obligation to inform you and may recommend you stop participating.
Practical takeaway: Before your screening visit, write down questions you want answered. Ask specifically about the visit schedule you'll follow, what side effects have been reported in earlier trial phases, what happens if you become pregnant (if applicable), whether the trial provides compensation for your time or travel costs, and how your data will be kept confidential. These conversations establish realistic expectations about what the next months or years will look like.
One fundamental truth about clinical trials: outcomes are uncertain. That's precisely why the research is happening. The experimental treatment may work better than current options, work similarly, work worse, or produce unexpected side effects. No trial researcher can predict in
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.